2026-10-13Neutral
-5.73%24 hours changeShares fell 5.73% on Q3 results after a second straight MedTech sales miss, with sales of $8.6bn versus an $8.71bn estimate.
read the report →Johnson & Johnson is a healthcare company operating two segments, Innovative Medicine (pharmaceuticals) and MedTech (medical devices). It competes with large pharma and device makers.
Shares fell 5.73% on Q3 results after a second straight MedTech sales miss, with sales of $8.6bn versus an $8.71bn estimate.
read the report →